What’s next after the commercial normalisation of marijuana? A new agency thinks it’s the normalisation of psychedelics. OEV Partners is a specialist shop offering strategy and creative to the businesses spearheading the psychedelic revolution in mental health, now that drugs like ketamine and ecstasy are shown to have amazing healing powers. “We want to tell the stories that bring these treatments into acceptance,” says co-founder and COO Chris Jenkins, “it’s about changing perceptions of them from drugs to medicines.” Their first job? – branding the world’s largest legal producer of LSD.
